Anti-glomerular basement membrane disease with exclusive renal impairment

Main Article Content

Laura Garcia de Andrade Oliveira
https://orcid.org/0009-0007-6353-4148
Aline Grosskopf Monich
https://orcid.org/0000-0002-7256-6674
João Luis dos Santos Carneiro
https://orcid.org/0000-0003-4160-1040
Rafael Fernandes Romani
https://orcid.org/0000-0002-8926-2837

Article Details

Section

Case Report

References

Alchi B, Griffiths M, Sivalingam M, Gallagher H, Sinha S. Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort. Nephrol Dial Transplant. 2015;30(5):814-21. Doi: 10.1093/ndt/gfu399

Gulati K, McAdoo SP. Anti–Glomerular Basement Membrane Disease. Rheum Dis Clin North Am. 2018;44(4):651-73. Doi: 10.1016/j.rdc.2018.06.011

Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol. 2013;17(5):603-6. Doi: Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides

McAdoo SP, Pusey CD. Anti-Glomerular Basement Membrane Disease. Clin J Am Soc Nephrol. 2017;12(7):1162-72. Doi: 10.2215/CJN.01380217

Van Daalen EE, Jennette JC, McAdoo SP, Tam FWK, Pusey CD, Alba MA, et al. Predicting Outcome in Patients with Anti-GBM Glomerulonephritis. Clin J Am Soc Nephrol. 2017;13(1):63-72. Doi: 10.2215/CJN.04290417